Aimée du Chatinier

Inducing and exploiting vulnerabilities for the treatment of liver cancer

Cun Wang, Serena Vegna, Haojie Jin et al. · Nature · 2019 · 430 citations

Medicine, Cancer Biology, Oncology +4

CDK12 inhibition mediates DNA damage and is synergistic with sorafenib treatment in hepatocellular carcinoma

Cun Wang, Hui Wang, Cor Lieftink et al. · Gut · 2019 · 114 citations

Life Sciences, Molecular Biology, Oncology +17

Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma

Aimée du Chatinier, Michaël H. Meel, Arvid I Das et al. · Neuro-Oncology Advances · 2022 · 40 citations · Full text

Medicine, Immunology, Oncology +16

AURKA and PLK1 inhibition selectively and synergistically block cell cycle progression in diffuse midline glioma

Dennis S. Metselaar, Aimée du Chatinier, Michaël H. Meel et al. · iScience · 2022 · 26 citations · Full text

Life Sciences, Oncology, Pharmacology +17

Rational combination of <scp>SHP2</scp> and <scp>mTOR</scp> inhibition for the treatment of hepatocellular carcinoma

Antonio Mulero‐Sánchez, Christel Ramirez, Aimée du Chatinier et al. · Molecular Oncology · 2023 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17